Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 161–161 | Cite as

Gefitinib

Acquired resistance: case report
Case report
  • 15 Downloads

Reference

  1. Minami S, et al. Osimertinib Did Not Respond to a Pulmonary Adenocarcinoma with Triple Mutations of Epidermal Growth Factor Receptor, G719S, T790M and S768I. Case Reports in Oncology 12: 178-182, No. 1, Jan-Apr 2019. Available from: URL: http://doi.org/10.1159/000497316 - JapanGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations